Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA’s Califf Defends CMS Drug Coverage Role, Blames Rx Industry Prices For US Health Woes
Jun 08 2023
•
By
Sarah Karlin-Smith
BIO CEO Rachel King interviewed FDA Commissioner Robert Califf on 7 June. • Source: Sarah Karlin
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Drug Pricing
More from Scrip